Hugin doubled price of live-saving cancer drug, report says July 23, 2018 10:00 amJuly 23, 2018 11:49 pm Jackie Trapp was diagnosed with multiple myeloma, a terminal but treatable blood cancer in 2015. After chemotherapy and a bone marrow transplant, she was put on Revlimid, a live-saving cancer drug that costs $21,197 a month. Even with good health... Read More